A radioligand for in vitro autoradiography of CSF1R in post-mortem CNS tissues.

IF 3.1 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING EJNMMI Research Pub Date : 2024-08-26 DOI:10.1186/s13550-024-01133-2
Catherine A Foss, Ravi Naik, Deepankar Das, Hyojin Cha, Il Minn, Andrew Hall, Paige Finley, Sophia Jiang Wu, Yong Du, Robert F Dannals, Martin G Pomper, Andrew G Horti
{"title":"A radioligand for in vitro autoradiography of CSF1R in post-mortem CNS tissues.","authors":"Catherine A Foss, Ravi Naik, Deepankar Das, Hyojin Cha, Il Minn, Andrew Hall, Paige Finley, Sophia Jiang Wu, Yong Du, Robert F Dannals, Martin G Pomper, Andrew G Horti","doi":"10.1186/s13550-024-01133-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Reactive microglia and recruited peripheral macrophages contribute to the pathogenesis of Alzheimer's dementia (AD). Monocytes, macrophages and microglia all express the marker colony-stimulating factor 1 receptor (CSF1R). 4-Cyano-N-(4-(4-methylpiperazin-1-yl)-2-(4-methylpiperidin-1-yl)phenyl)-1H-pyrrole-2-carboxamide (1) is a high-affinity antagonist for CSF1R. We report the radiosynthesis of both [<sup>3</sup>H]1 and [<sup>11</sup>C]1. The PET imaging properties of [<sup>11</sup>C]1 in mice and baboon were investigated. [<sup>3</sup>H]1 was studied in B<sub>max</sub> measurement in post-mortem autoradiography in the frontal cortex, inferior parietal cortex and hippocampus from donors diagnosed with AD and age-matched controls. In vitro binding affinity of 1 was measured commercially. Nor-methyl-1 precursor was radiolabeled with [<sup>11</sup>C]iodomethane or [<sup>3</sup>H]iodomethane to produce [<sup>11</sup>C]1 and [<sup>3</sup>H]1, respectively. Ex vivo brain biodistribution of [<sup>11</sup>C]1 was compared in normal mice versus lipopolysaccharide-administered (LPS) murine model of neuroinflammation. Dynamic PET imaging was performed in a healthy male Papio anubis baboon. Post-mortem autoradiography with [<sup>3</sup>H]1 was performed in frozen sections using a standard saturation binding technique.</p><p><strong>Results: </strong>Compound 1 exhibits a high in vitro CSF1R binding affinity (0.59 nM). [<sup>11</sup>C]1 was synthesized with high yield. [<sup>3</sup>H]1 was synthesized similarly (commercially). Biodistribution of [<sup>11</sup>C]1 in healthy mice demonstrated moderate brain uptake. In LPS-treated mice the brain uptake of [<sup>11</sup>C]1 was ~ 50% specific for CSF1R. PET/CT [<sup>11</sup>C]1 study in baboon revealed low brain uptake (0.36 SUV) of [<sup>11</sup>C]1. Autoradiography with [<sup>3</sup>H]1 gave significantly elevated B<sub>max</sub> values in AD frontal cortex versus control (47.78 ± 26.80 fmol/mg vs. 12.80 ± 5.30 fmol/mg, respectively, P = 0.023) and elevated, but not significantly different binding in AD hippocampus grey matter and inferior parietal cortex (IPC) white matter.</p><p><strong>Conclusions: </strong>Compound 1 exhibits a high in vitro CSF1R binding affinity. [<sup>11</sup>C]1 specifically labels CSF1R in the mouse neuroinflammation, but lacks the ability to efficiently cross the blood-brain barrier in baboon PET. [<sup>3</sup>H]1 specifically labels CSF1R in post-mortem human brain. The binding of [<sup>3</sup>H]1 is significantly higher in the post-mortem frontal cortex of AD versus control subjects.</p>","PeriodicalId":11611,"journal":{"name":"EJNMMI Research","volume":"14 1","pages":"76"},"PeriodicalIF":3.1000,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11347546/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13550-024-01133-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Reactive microglia and recruited peripheral macrophages contribute to the pathogenesis of Alzheimer's dementia (AD). Monocytes, macrophages and microglia all express the marker colony-stimulating factor 1 receptor (CSF1R). 4-Cyano-N-(4-(4-methylpiperazin-1-yl)-2-(4-methylpiperidin-1-yl)phenyl)-1H-pyrrole-2-carboxamide (1) is a high-affinity antagonist for CSF1R. We report the radiosynthesis of both [3H]1 and [11C]1. The PET imaging properties of [11C]1 in mice and baboon were investigated. [3H]1 was studied in Bmax measurement in post-mortem autoradiography in the frontal cortex, inferior parietal cortex and hippocampus from donors diagnosed with AD and age-matched controls. In vitro binding affinity of 1 was measured commercially. Nor-methyl-1 precursor was radiolabeled with [11C]iodomethane or [3H]iodomethane to produce [11C]1 and [3H]1, respectively. Ex vivo brain biodistribution of [11C]1 was compared in normal mice versus lipopolysaccharide-administered (LPS) murine model of neuroinflammation. Dynamic PET imaging was performed in a healthy male Papio anubis baboon. Post-mortem autoradiography with [3H]1 was performed in frozen sections using a standard saturation binding technique.

Results: Compound 1 exhibits a high in vitro CSF1R binding affinity (0.59 nM). [11C]1 was synthesized with high yield. [3H]1 was synthesized similarly (commercially). Biodistribution of [11C]1 in healthy mice demonstrated moderate brain uptake. In LPS-treated mice the brain uptake of [11C]1 was ~ 50% specific for CSF1R. PET/CT [11C]1 study in baboon revealed low brain uptake (0.36 SUV) of [11C]1. Autoradiography with [3H]1 gave significantly elevated Bmax values in AD frontal cortex versus control (47.78 ± 26.80 fmol/mg vs. 12.80 ± 5.30 fmol/mg, respectively, P = 0.023) and elevated, but not significantly different binding in AD hippocampus grey matter and inferior parietal cortex (IPC) white matter.

Conclusions: Compound 1 exhibits a high in vitro CSF1R binding affinity. [11C]1 specifically labels CSF1R in the mouse neuroinflammation, but lacks the ability to efficiently cross the blood-brain barrier in baboon PET. [3H]1 specifically labels CSF1R in post-mortem human brain. The binding of [3H]1 is significantly higher in the post-mortem frontal cortex of AD versus control subjects.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于中枢神经系统死后组织中 CSF1R 体外自显影的放射性配体。
背景:反应性小胶质细胞和被招募的外周巨噬细胞是阿尔茨海默氏症痴呆(AD)的发病机制之一。单核细胞、巨噬细胞和小胶质细胞都表达标志物集落刺激因子 1 受体(CSF1R)。4-氰基-N-(4-(4-甲基哌嗪-1-基)-2-(4-甲基哌啶-1-基)苯基)-1H-吡咯-2-甲酰胺(1)是一种高亲和力的 CSF1R 拮抗剂。我们报告了 [3H]1 和 [11C]1 的放射合成。研究了[11C]1在小鼠和狒狒体内的 PET 成像特性。研究了[3H]1在被诊断为AD的供体和年龄匹配的对照组的额叶皮层、下顶叶皮层和海马中的尸检自显影Bmax测量。1 的体外结合亲和力是通过商业途径测定的。用[11C]碘甲烷或[3H]碘甲烷对正甲基-1前体进行放射性标记,分别生成[11C]1和[3H]1。比较了[11C]1在正常小鼠和给药脂多糖(LPS)小鼠神经炎症模型中的体内脑生物分布。在一只健康的雄性巴布亚狒狒身上进行了动态 PET 成像。采用标准饱和结合技术对冷冻切片进行了[3H]1死后自动放射成像:结果:化合物 1 具有很高的体外 CSF1R 结合亲和力(0.59 nM)。高产率合成了[11C]1。[3H]1的合成与此类似(商业化)。[11C]1 在健康小鼠体内的生物分布显示了适度的脑摄取。在经 LPS 处理的小鼠中,[11C]1 对 CSF1R 的脑摄取特异性约为 50%。在狒狒体内进行的 PET/CT [11C]1 研究显示,[11C]1 的脑摄取量较低(0.36 SUV)。用[3H]1进行的自显影显示,AD额叶皮质的Bmax值较对照组明显升高(分别为47.78 ± 26.80 fmol/mg vs. 12.80 ± 5.30 fmol/mg,P = 0.023),AD海马灰质和下顶叶皮质(IPC)白质的结合率升高,但无明显差异:结论:化合物 1 具有很高的体外 CSF1R 结合亲和力。在小鼠神经炎症中,[11C]1 能特异性标记 CSF1R,但在狒狒 PET 中却不能有效穿过血脑屏障。[3H]1能特异性标记死后人脑中的CSF1R。与对照组相比,[3H]1在AD患者死后额叶皮层中的结合率明显更高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
EJNMMI Research
EJNMMI Research RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING&nb-
CiteScore
5.90
自引率
3.10%
发文量
72
审稿时长
13 weeks
期刊介绍: EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies. The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.
期刊最新文献
In vitro and ex vivo evaluation of preclinical models for FAP-targeted theranostics: differences and relevance for radiotracer evaluation. cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancer. P2X 7-receptor binding in new-onset and secondary progressive MS - a [11C]SMW139 PET study. PET imaging of GABAA receptors in pancreatic islets by [11C]flumazenil. Imaging tumor and ascites-associated macrophages in a mouse model of metastatic ovarian cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1